DJS Law Group reminds investors about GeneDx securities lawsuit
DJS Law Group said investors who bought GeneDx shares during the class period may contact the firm about a securities class action.
DJS Law Group said in an Aug. 3, 2026, press release that it is reminding investors about a class action lawsuit against GeneDx Holdings Corp., which trades on Nasdaq as WGS.
The release says the case alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5. It lists a class period from April 16, 2025, through May 4, 2026.
Investors who bought GeneDx shares during that period may be eligible to seek appointment as lead plaintiff in the case, according to the release. It also says lead-plaintiff status is not required to take part in any recovery.
Context and background
According to the press release, the complaint says GeneDx made false and misleading statements to the market. It says the company later reported a drop in adjusted gross margin in the first quarter of 2026 and lowered projected full-year earnings.
The release says those public statements were false and materially misleading throughout the class period. The item is attorney advertising and was issued by DJS Law Group in Eastchester, New York.
What the firm said
The release encourages shareholders who purchased WGS shares during the class period to contact the firm about possible lead plaintiff appointments. It identifies David J. Schwartz as a contact in the notice.
What happens next
The press release does not provide a court update or a hearing date. It says investors who want more information should contact the firm listed in the notice.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.